Treatment with niacin lowers ADMA.
Westphal
Sabine
S
Borucki
Katrin
K
Luley
Claus
C
Martens-Lobenhoffer
Jens
J
Bode-Böger
Stefanie M
SM
D000328:Adult; D000368:Aged; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood / Q000187:drug effects; D050197:Atherosclerosis / Q000097:blood* / Q000517:prevention & control; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000627:therapeutic use*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D012307:Risk Factors; D016896:Treatment Outcome
D015415:Biomarkers; D000960:Hypolipidemic Agents; D009525:Niacin; C018524:N,N-dimethylarginine; D001120:Arginine; D019001:Nitric Oxide Synthase